Dorsey Wright & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,504
| Closed | -$1.59M | – | 359 |
|
|
2022
Q4 | $1.59M | Buy |
+5,504
| New | +$1.59M | 0.46% | 95 |
|
|
2022
Q2 | $1.66M | Buy |
+5,902
| New | +$1.66M | 0.49% | 91 |
|
|
2020
Q4 | – | Sell |
-12,354
| Closed | -$3.36M | – | 391 |
|
|
2020
Q3 | $3.36M | Sell |
12,354
-868
| -7% | -$236K | 0.61% | 46 |
|
|
2020
Q2 | $3.84M | Sell |
13,222
-586
| -4% | -$170K | 0.78% | 30 |
|
|
2020
Q1 | $3.29M | Buy |
+13,808
| New | +$3.29M | 1.25% | 28 |
|
|
2019
Q2 | – | Sell |
-16,505
| Closed | -$3.04M | – | 342 |
|
|
2019
Q1 | $3.04M | Buy |
+16,505
| New | +$3.04M | 0.73% | 70 |
|
|
2018
Q4 | – | Sell |
-17,087
| Closed | -$3.29M | – | 353 |
|
|
2018
Q3 | $3.29M | Buy |
17,087
+577
| +3% | +$111K | 0.6% | 73 |
|
|
2018
Q2 | $2.81M | Buy |
16,510
+1,382
| +9% | +$235K | 0.41% | 74 |
|
|
2018
Q1 | $2.47M | Buy |
15,128
+349
| +2% | +$56.9K | 0.38% | 75 |
|
|
2017
Q4 | $2.22M | Sell |
14,779
-8,651
| -37% | -$1.3M | 0.4% | 82 |
|
|
2017
Q3 | $3.56M | Buy |
23,430
+10,830
| +86% | +$1.65M | 0.82% | 61 |
|
|
2017
Q2 | $1.62M | Buy |
+12,600
| New | +$1.62M | 0.5% | 96 |
|